0001235802-23-000071.txt : 20230626 0001235802-23-000071.hdr.sgml : 20230626 20230626162641 ACCESSION NUMBER: 0001235802-23-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230623 FILED AS OF DATE: 20230626 DATE AS OF CHANGE: 20230626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Semba Charles Pauling CENTRAL INDEX KEY: 0001872863 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 231042681 MAIL ADDRESS: STREET 1: TWO CARLSON PARKWAY, SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: 301 CARLSON PARKWAY STREET 2: SUITE 210 CITY: MINNEAPOLIS STATE: MN ZIP: 55305 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-06-23 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001872863 Semba Charles Pauling 301 CARLSON PARKWAY, SUITE 210 MINNEAPOLIS MN 55305 1 0 0 0 0 Voting Common Shares, no par value per share 2023-06-23 4 P 0 12787 3.91 A 29943 D Includes 12,867 shares issuable on vesting of a restricted stock unit award granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan. /s/ Amy E. Culbert, attorney-in-fact 2023-06-26